PSA divided by prostate volume; helps interpret the grey-zone PSA (4–10 ng/mL).

What it is and when to use it

PSA density (PSAD) is the serum total PSA concentration divided by prostate volume measured by ultrasound (transrectal or transabdominal) or MRI, expressed in ng/mL per cm³. It adjusts the PSA value for prostate size to improve discrimination between benign prostatic hyperplasia and clinically significant prostate cancer, particularly in men with PSA in the grey zone (roughly 4–10 ng/mL). It is used to support biopsy and surveillance decisions, and the EAU (European Association of Urology) guideline includes it as an auxiliary parameter within the prostate cancer diagnostic pathway.

How to interpret it

PSAD is calculated by dividing total PSA (ng/mL) by prostate volume (cm³). The most widely used threshold is 0.15 ng/mL/cm³: values at or above 0.15 raise the probability of clinically significant cancer and strengthen the indication for biopsy, whereas lower values make significant cancer less likely. In the context of multiparametric MRI, a low PSAD (often below 0.10–0.15) is used to support avoiding or deferring biopsy in equivocal PI-RADS lesions (typically PI-RADS 3); higher values increase risk. Thresholds are indicative and must be integrated with age, digital rectal examination, MRI and clinical history.

Limitations and when not to use it

Validated chiefly in men with elevated PSA (especially 4–10 ng/mL) being assessed for prostate biopsy. Reliability depends critically on accurate measurement of prostate volume; interobserver variability and imaging method (ultrasound vs MRI) can change the result. It does not apply reliably after recent prostate manipulation, prostatitis, urinary retention, or under 5-alpha-reductase inhibitors (finasteride, dutasteride), which lower PSA by roughly half after 6–12 months. PSAD does not diagnose cancer or determine its grade or stage: it only estimates risk and does not replace MRI, biopsy or histological evaluation.

Frequently asked questions

What is a normal PSA density value?

The most commonly used reference threshold is 0.15 ng/mL/cm³; values below it are considered lower risk and values above raise suspicion of clinically significant cancer. It is indicative and should be interpreted alongside other clinical and imaging findings.

How is PSA density calculated?

Divide the total blood PSA (ng/mL) by the prostate volume (cm³) measured by ultrasound or MRI. The result is expressed in ng/mL/cm³.

Can PSA density help avoid a biopsy?

It can: combined with multiparametric MRI, a low PSAD supports avoiding or deferring biopsy in equivocal lesions, but the decision is always individualized and not based on this value alone.